Archive for the ‘Calendar/Events’ Category

February 2017 Lunch – “One Health – It’s All Connected”

March 22, 2017

“One Health – It’s All Connected”

The One Health concept recognizes that the health of people is connected to the health of animals and the environment. The goal of One Health is to encourage the collaborative efforts of multiple disciplines-working locally, nationally, and globally-to achieve the best health for people, animals, and our environment.  Sixty percent of infectious diseases in people are spread from animals and the interactions between the points of this triad are changing more rapidly and dynamically than ever before.  Our panel will discuss how looking at the bigger picture will shape drug development and impact innovation and research efforts going forward.

Panelists:

Josh Johnson

 General Manager

Benchmark Biolabs

Reza J. Rasoulpour, Ph.D.

 Global Predictive Safety Center LeaderRegulatory Sciences, R&D

Dow AgroSciences, LLC

 Kristin Bloink

Senior Director

 Global Research and External Innovation 

 Elanco Animal Health

Moderator:


Deborah Pollack-Milgate 

Partner

Barnes & Thornburg LLP

The Indiana Health Industry Forum and Barnes & Thornburg LLP partner to present a monthly seminar series on critical issues in life science. Each month, at lunch, a policymaker or a panel in the field of life science will be available to answer questions concerning the major challenges and opportunities in the life science industry. We hope you will join us.

 

ShareVault Webinar – October 13, 2016

October 7, 2016

ShareVault

ShareVault Webinar – “Must-Know Finance Concepts for Life Sciences Valuations Part 2:  A More Detailed Explanation of Concepts”

Thursday, October 13, 2016, 11am-12pm PST / 2pm-3pm EST

Speakers:  John Selig & Jeff Karan, Managing Partners, Mavericks Capital

This webinar is a continuation of the first webinar, entitled “Must-Know Finance Concepts for Life Sciences Valuations,” and goes into more detail on the key concepts and most common methodologies used to evaluate life sciences assets.

Questions answered in Part 2 include:

  • Which asset valuation methodology is most used by big pharma to evaluate possible partners or acquisitions?
  • An explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital and present value
  • What are some cash flow examples for a situation when the asset is early in the product lifecycle, for out-licensed, and for in-licensed products?
  • How do my expected deal terms relate to my forecast cash flows? How can I use this to make better decisions on licensing timing?

And more.

If you are an entrepreneur who plans to raise (or currently is raising) financing, licensing an asset or selling your company, a private investor who wants to estimate and negotiate start-up share value, or any other professional who is active in the life sciences investing sector, you’ll benefit from this more detailed explanation of life sciences valuation methodologies.

At the end of their presentation, the speakers will respond to questions from the audience.

Click here to learn more and register:  http://bit.ly/2dtz5tN

IHIF is a Proud Partner in National Health IT Week

August 21, 2016

This September, IHIF — as a partner in the advancement of health information technology to help improve healthcare —is a Proud Partner in National Health IT Week.  National Health IT Week is the premier event offering all healthcare stakeholders an opportunity to unite under one banner, expressing the benefits that health information technology (IT) brings to U.S. healthcare. “The Value of Health IT.”

Comprehensive health care reform is not possible without system-wide adoption of health information technology, which improves the quality of healthcare delivery, increases patient safety, decreases medical errors, and strengthens the interaction between patients and healthcare providers.

With Meaningful Use now providing the way forward, eligible providers across the country increasingly understand the benefits for themselves and their patients, and are adopting Meaningful Use compliant electronic health records.

Initiated in 2006 by the Healthcare Information and Management Systems Society (HIMSS), National Health IT Week has emerged as a landmark occasion for using health IT as part of the overall solution to improve America’s healthcare as a bipartisan, federally led, market driven initiative.

The Week consists of events across the country, including National Health IT Weekparticipants —vendors, provider organizations, payers, pharmaceutical/biotech companies, government agencies, industry/professional associations, research foundations, and consumer protection groups— all working together to elevate national attention to the advantages of advancing health IT.

View our full list of partners and updates on the Week’s events. Working together with our growing coalition of stakeholders, IHIF is helping to transform healthcare for all.

Deadlines to Apply for NCATS Funding Opportunities are Coming Up September 6!

August 21, 2016

This is a reminder that the National Center for Advancing Translational Sciences (NCATS) has several open Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program funding opportunities designed to help advance and commercialize translational research technologies. NCATS encourages applications in these four research areas of interest: drug discovery and development, diagnostics and devices, bioinformatics and information technology, and clinical research.

 

All opportunities below have an application deadline of Sept. 6, 2016, 5 p.m. local time.

 

2016 Omnibus Solicitation

Small businesses, research and technology transfer organizations are eligible to apply for the 2016 Omnibus Solicitation. Applications may address any stage of translation, from target validation through pre-clinical and clinical evaluation to intervention, implementation and dissemination. Review NCATS’ research priorities to determine its areas of interest.

Other Funding Opportunities

SBIR Direct Phase II

Small businesses that have accomplished the objectives of a Phase I SBIR grant through non-SBIR funds are able to apply for SBIR direct-to-Phase II funding. Applicants must demonstrate the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential.

  • PAR-15-288: Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science
  • PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development

 

SBIR Technology Transfer

This funding opportunity encourages SBIR grant applications from small business concerns for projects to transfer technology out of the NIH intramural research labs into the private sector.

  • PA-15-354: SBIR Technology Transfer (R43/R44)

 

Platform Delivery Technologies for Nucleic Acid Therapeutics

This funding opportunity is designed to incentivize small businesses to generate new technologies and products for delivering nucleic acids into cells and tissues for the purpose of treatment or prevention of human disease.

  • PA-14-307: Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
  • PA-14-308: Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)

 

Development of Appropriate Pediatric Formulations and Drug Delivery Systems

Applications must address different and complementary research needs for the development of appropriate pediatric drug formulations in different age groups.

  • PAR-13-345: Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)
  • PAR-13-346: Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41)

 

Learn more about current funding opportunities for small business at NCATS Small Business, including eligibility requirements and research priorities. Need help? Contact NCATS SBIR and STTR to discuss your project idea.

 

Connect with NCATS! Like us on Facebook and follow us on Twitter. Use #NCATSsbir and join the online conversation.

 

***

NCATS’ SBIR and STTR programs are engines of innovation for developing and commercializing tools, technologies and intervention platforms to support the creation of new therapeutics and diagnostics. SBIR and STTR are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

NCI SBIR/STTR Webinar & Great Funding Opportunity by JLABS!

July 8, 2016

The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center will be participating in the Women in Biotech webinar on Tuesday, July 14, 2016. NCI SBIR Program Staff Kory Hallett, Ph.D. will be speaking at the webinar about NCI SBIR/STTR funding opportunities and application tips. Register today for this free webinar and get in-depth information about SBIR and STTR programs.

In addition to the webinar, we would like to share with you a great funding opportunity that could help fuel your cancer research. The JLABS QuickFire Challenge will award up to $500,000 in a research grant and entrance to JLABS. We hope you find the contest useful for advancing your cancer research. Detailed information about the webinar and the QuickFire Challenge can be found below.

If you have any questions about the webinar or the NCI SBIR/STTR programs, please send us an email at ncisbir@mail.nih.gov.

Securing SBIR and STTR Funding: Support for Women
Entrepreneurs and Researchers in Biotech

Thursday, July 14, 2016, 1:00 – 2:00 p.m. ET | 10:00 – 11:00 a.m. PT

Register Today

Speakers:

  • Kory Hallett, Ph.D., Program Staff, AAAS Science & Technology Policy Fellow, NCI, NIH
  • Cartier Esham, Ph.D., Executive Vice President, Emerging Companies, Biotechnology Innovation Organization (BIO)
  • Lili M. Portilla, M.P.A., Director, Strategic Alliances, NCATS, NIH
  • Stephanie Fertig, M.B.A. Director, NINDS Small Business Programs, NIH

The webinar will feature:

  • An overview of SBIR and STTR programs and funding opportunities
  • Examples and case studies of women founders of bio- and healthcare-technology early-stage businesses

Tips and tools for applying for funding, and resources available for women entrepreneurs and researchers from socially and economically disadvantaged backgrounds

 

JLABS QuickFire Challenge

[APPLY HERE]

Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. aim to improve the health and wellness of people around the world. To that end, there is a passionate and engaged workforce across the consumer, medical device and pharmaceutical units who are interested in finding and deploying comprehensive, end to end, integrated solutions which take into account the world in which we live today. Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. are bringing together the consumer, medical device and pharmaceutical sectors to award a prize or a series of prizes to the person or team(s) who submits the best idea, technology, or solution that will address a critical health need for the world’s population. Please check out the areas of interest, with an emphasis on lung cancer and metabolism.

Solutions will be evaluated based on their ability to meet the following criteria:

  • Address a particular cohort with a critical unmet medical need in strategic areas of interest, such as lung cancer and metabolic diseases.
  • Integrate a novel approach that combines pharmaceutical, devices and/or consumer health solutions.
  • Address part or all of the spectrum of prevention, interception and cure.
  • Outline how the award would help them reach a critical milestone within the time frame of a single year and provide a full “time-to-market” plan for their solution.

The deadline to apply is August 31, 2016, and winners will be announced by the end of the year.

IHIF Annual Meeting Convenes Industry Leaders

May 16, 2016

Cancer Moonshot and Strategic Plan Anchor Agenda

Contact: Kristin Jones, President and CEO
Indiana Health Industry Forum
kjones@ihif.org or 317-686-0994

INDIANAPOLIS (May 9, 2016) — The Indiana Health Industry Forum is kicking-off its 2016 Annual Meeting and conference for the state’s life science industry today.  The event’s opening reception and VIP Dinner will take place at the Alexander Hotel – a Dolce Property in downtown Indianapolis.   For the third year, the reception will feature a student research poster display highlighting some of the biomedical student projects from the McKenzie Center for Innovation and Technology.  Tuesday’s meeting will take place at the Eli Lilly and Co. headquarters in conjunction with the company’s 140th Anniversary celebration.

The conference keynote speaker will be Michael Weingarten, the director of the National Cancer Institute’s SBIR grant program.  His presentation will cover SBIR best practices, a discussion of the agency’s translational services, programs, and awards, tips on writing a successful application, and touch on the agency’s role in the national Cancer Moonshot initiative.  A follow-on panel will further explore Indiana’s Contribution to the Cancer Moonshot.  Panelists will include: Representative Larry Bucshon, M.D, (IN 8th); Dr. Sherry Harbin, Geniphys; Bryan Hannon, American Cancer Society; Dr. Mervin Yoder, IU School of Medicine, and Scott Shortenhaus, Eli Lilly and Co.  The panel moderator will be Deborah Pollack-Milgate with Barnes & Thornburg.

IHIF will also be kicking off Roadmap 2020 and beginning collection of recommendations for the development of the next industry driven strategic plan.  More information on Roadmap 2020 and how to submit recommendations for consideration can be found on the IHIF website at www.ihif.org/pages/roadmap2020.  A panel discussion covering trends in strategic plan topic areas will include remarks from: Sue Ellspermann, Former Lt. Governor of the State of Indiana , Roger Harvey, Bose Public Affairs Group; Alex Smith, Deloitte; Calvin Thomas IV, Ivy Tech Corporate College; and Matthew Waninger, Ph.D., MED Institute.   The panel will be moderated by Eric Marr, Founder and President of Diversity Accords and current chair of the IHIF Board of Directors.

IHIF would like to thank the following sponsors for their support:  Headline Sponsor: Eli Lilly and Co., Gold Sponsors: Barnes & Thornburg and Cook Medical, Silver Sponsors: CAI and Hoosiers Work for Health, Event Sponsors: Konica Minolta and ShareVault.  IHIF would also like to recognize some of our partners: The Catherine Peachey Fund in support of the Komen Tissue Bank, Lodestone Insights, Cabello Associates, and the BIO Business Solutions Program.

About IHIF

The Indiana Health Industry Forum (IHIF) is a statewide trade association representing members of Indiana’s health science business community.  The diverse members of IHIF generate the collective voice of the state’s health and life science industry.  Our mission is to connect key stakeholders to: enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation.  For more information and to become a member, please visit www.ihif.org

February 2016 Life Science Lunch

February 16, 2016

Clinical Trials from a Study Site Perspective

The conduct of clinical research requires effective working relationships between the study sites that execute clinical trials and the sponsors that design the trials and provide product for testing. With much riding on study outcomes, understanding what happens behind the scenes may help you design more effective trials.  This month’s discussion will explore some of the bigger technical challenges to running a clinical research site, including:
•    Types of clinical trials, sponsors and study sites
•    Staffing/Workforce requirements,  needs, and challenges
•    Managing study site and sponsor expectations
•    Role of an IRB
•    Subject recruitment, screening, informed consent and enrollment
•    Managing costs

Moderator:

Deborah Pollack-Milgate, Partner

Barnes & Thornburg, LLP

Panelists:

Diana Caldwell

President and Founder

Pearl Pathways

Jenna Sallee

Executive Director

Orthopedic Research Foundation, Inc.

Dr. Scott Denne

Director

CTSI Clinical Research Center at IUPUI

About the Series

The Indiana Health Industry Forum and Barnes & Thornburg LLP partner to present a monthly seminar series on critical issues in life science. Each month, at lunch, a policymaker or a panel in the field of life science will be available to answer questions concerning the major challenges and opportunities in the life science industry. We hope you will join us.

There is no charge to attend, but please register so we know how many lunches to order. Please see registration page for details. Some of the discussion questions will be submitted to the speakers in advance.

For information on upcoming programs, please visit the Life Science Lunch website – http://www.ihif.org/pages/lifescience

Supporting Materials Mentioned in Today’s Discussion

New “Time Is Precious” Video from BIO

TIPIntro

Learn more at TimeIsPrecious.Life

“Research in Your Backyard: Developing Cures, Creating Jobs” PhRMA Report on Clinical Research in Indiana

Hospitalar 2016

February 8, 2016

Event Summary
The 22nd annual editon of HOSPITALAR takes place May 17‐20, 2016 in São Paulo,
Brazil. HOSPITALAR is an internatonal trade fair for products, equipment, services,
and technology for hospitals, health clinics, and laboratories. The show is the most
complete and specialized healthcare fair in Brazil and North America. The fair is
considered as the premier platorm for new technologies, representng a great
opportunity to learn about innovatve products and services for hospitals, health
clinics, and laboratories.
HOSPITALAR is a mult‐sector trade fair, featuring 1,250 Brazilian and internatonal
exhibitors, launching products or services and meetng potental and already
existng clients. Exclusively dedicated to healthcare professionals, HOSPITALAR 2015
received over 98,000 visitors, including 1500 foreign buyers, among doctors, nurses,
PTs, administrators, distributors and other professionals interested in the health
care area, coming from all over Brazil and Latn America.

The U.S. Commercial Service will be offering Gold Key Services (GKS) to U.S.
companies attending the show.

Learn More

IHIF 2016 Legislative Breakfast and Industry Briefing

January 18, 2016

 

An IHIF Signature Event

Presented by:

 Print     HWFH new logo     IMDMC 2013 Logo

You are Invited!

January 27, 2016

 

Downtown Indianapolis Hilton Hotel

120 W. Market Street

Monument Hall (Lower Level)

 

With Featured Speakers

Lt. Governor Sue Ellspermann

and

Rep. Ed Clere, House Public Health Committee

Due to a schedule change, Senator Pat Miller will be unable to join us for the program.  We are pleased to announce that Lt. Governor Sue Ellsperman will be with us to share her thoughts on the direction of the life science industry in Indiana.  Rep. Ed Clere will provide an assessment of the 2016 Legislative Session with special regard for public health matters.

Registration 7:15 am

Program 7:30 – 8:30 am

Welcome and Introduction

Kristin Jones, IHIF

  IMDMC Legislative Update

Kathy Heuer, Executive Director

“The Value of Medicines”

Saiza Elayda, PhRMA

The Indiana Health Industry Forum is a state-based trade association for members of Indiana’s health and life science manufacturing community.  The goal of the annual legislative breakfast briefing is to educate and engage IHIF members on Federal and State public policy issues and activities.  The event is open to member companies of IHIF, the Indiana Medical Device Manufacturers Council (IMDMC), the Hoosiers Work for Health/PhRMA task force, and all members of the Indiana General Assembly.  There is no charge to attend but please register.  For more information on IHIF, please visit www.ihif.org

 

Please register here to attend the breakfast briefing

IHIF Welcomes Mindray for First Discovery Days Program

January 7, 2016

 

Momentum Logo June 2014

Discovery Days

February 17-18, 2016

Mindray logo

 

The Indiana Health Industry Forum is pleased to announce that we have finalized dates for a company visit to Indiana by Mindray.   IHIF will be hosting company representatives here in Indianapolis on February 17th -18th for our first Discovery Days program!  Mindray representatives are interested in meeting Indiana businesses working in two areas: 1) in-vitro diagnostics and 2) assistive technologies, including health IT applications.  They are interested in meeting with both companies with established products looking to expand their market into China as well as identifying novel technologies that could use a developmental partner.   Mindray offers investment capital, assistance with CFDA approval, and joint venture opportunities.

About Mindray Medical International

Mindray was founded in 1991 in Shenzhen, China, with a mission to deliver high-quality, competitively priced medical devices to make healthcare more accessible and affordable around the world. Over the last 17 years, we have become a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence. We are expanding our distribution network, sales and sales support staff to bring our products closer to end users. We currently have 29 local sales and service offices in China, as well as sales and service subsidiaries in Amsterdam, Istanbul, London, Mexico City, Moscow, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver.   For more information, please visit http://www.mindraynorthamerica.com/about/

Apply to meet

If you have technologies or know of companies that may be interested in meeting with Mindray’s technology development representatives, please let us know!  IHIF is working to identify a pool of potential companies/technologies and then, working with Mindray, we’ll put together a short list of invitees to a 1-on-1 meeting with them here in Indianapolis.   Please submit a short (1 page) description of the company/technology to get things started.    Please submit descriptions to IHIF at info@ihif.org.   We will begin notifying accepted applicants by January 20th.